Health
Rheumatoid arthritis drug improves outcomes in severely ill COVID-19 patients, finds new trial – News-Medical.Net
Tocilizumab, an anti-inflammatory drug used to treat rheumatoid arthritis, improves outcomes in severely ill COVID-19 patients, finds the results of a new trial…
Tocilizumab, an anti-inflammatory drug used to treat rheumatoid arthritis, improves outcomes in severely ill COVID-19 patients, finds the results of a new trial conducted in hospitals across India — one of the world’s most ethnically diverse countries. Researchers from the University of Bristol and Medanta Institute of Education and Research in India who led the study, published in The Lancet Respiratory Medicine, say it adds to existing evidence supporting the drug’s use in critically ill patients.
…
-
Noosa News20 hours agoTwo trapped and fighting for life after major three-vehicle crash in Brisbane
-
Business21 hours agoUp 105% in a year, are Pro Medicus shares still a good buy today?
-
Business19 hours agoEverything you need to know about the Coles dividend
-
Noosa News16 hours agoQueensland man sentenced to four years imprisonment after string of terror offences